FDA Places Hold on Gilead’s Injectable HIV Drug Over Possible Glass Contaminants

The FDA has put a clinical hold on Gilead Sciences’ injectable HIV drug lenacapavir because of the risk of glass particles from the vials getting into the medication.
Source: Drug Industry Daily